| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENZ | Common Stock | Options Exercise | $0 | +10,640 | +3.6% | $0.000000 | 307,120 | 21 Feb 2024 | Direct | F1 |
| transaction | ENZ | Common Stock | Tax liability | $0 | -5,823 | -1.9% | $0.000000 | 301,297 | 21 Feb 2024 | Direct | F2 |
| transaction | ENZ | Common Stock | Award | $0 | +150,000 | +50% | $0.000000 | 451,297 | 23 Feb 2024 | Direct | F3 |
| holding | ENZ | Common Stock | 45,065 | 21 Feb 2024 | 401k |
| Id | Content |
|---|---|
| F1 | Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023. |
| F2 | Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements. |
| F3 | The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control. |